|
1.
|
Wafaisade A, Lefering R, Bouillon B, Sakka
SG, Thamm OC, Paffrath T, Neugebauer E and Maegele M: Trauma
Registry of the German Society for Trauma Surgery: Epidemiology and
risk factors of sepsis after multiple trauma: An analysis of 29,829
patients from the Trauma Registry of the German Society for Trauma
Surgery. Crit Care Med. 39:621–628. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Coimbra R: From the trauma surgeon's
viewpoint: Multiple injuries - which cavity to open first? J Trauma
Nurs. 12:7–9. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Dellinger RP, Levy MM, Carlet JM, Bion J,
Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale
R, et al: Surviving Sepsis Campaign: International guidelines for
management of severe sepsis and septic shock: 2008. Intensive Care
Med. 34:17–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Balk RA: Severe sepsis and septic shock:
Definitions, epidemiology, and clinical manifestations. Crit Care
Clin. 16:179–192. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Hanna NF: Sepsis and septic shock. Adv
Emerg Nurs J. 25:158–165. 2003.
|
|
6.
|
Widera D, Mikenberg I, Elvers M,
Kaltschmidt C and Kaltschmidt B: Tumor necrosis factor α triggers
proliferation of adult neural stem cells via IKK/NF-kappaB
signaling. BMC Neurosci. 7:642006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Lemaître N, Sebbane F, Long D and
Hinnebusch BJ: Yersinia pestis YopJ suppresses tumor
necrosis factor alpha induction and contributes to apoptosis of
immune cells in the lymph node but is not required for virulence in
a rat model of bubonic plague. Infect Immun. 74:5126–5131. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Greenberg JD, Kremer JM, Curtis JR,
Hochberg MC, Reed G, Tsao P, Farkouh ME, Nasir A, Setoguchi S and
Solomon DH: CORRONA Investigators: Tumour necrosis factor
antagonist use and associated risk reduction of cardiovascular
events among patients with rheumatoid arthritis. Ann Rheum Dis.
70:576–582. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Yu M, Zhou X, Niu L, Lin G, Huang J, Zhou
W, Gan H, Wang J, Jiang X, Yin B and Li Z: Targeting transmembrane
TNF-α suppresses breast cancer growth. Cancer Res. 73:4061–4074.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Liang Y, Li X, Zhang X, Li Z, Wang L, Sun
Y, Liu Z and Ma X: Elevated levels of plasma TNF-α are associated
with microvascular endothelial dysfunction in patients with sepsis
through activating the NF-κB and p38 mitogen-activated protein
kinase in endothelial cells. Shock. 41:275–281. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Rice TW and Bernard GR: Therapeutic
intervention and targets for sepsis. Annu Rev Med. 56:225–248.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Alexander JJ, Jacob A, Cunningham P,
Hensley L and Quigg RJ: TNF is a key mediator of septic
encephalopathy acting through its receptor, TNF receptor-1.
Neurochem Int. 52:447–456. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Kocabaş E, Sarikçioğlu A, Aksaray N,
Seydaoğlu G, Seyhun Y and Yaman A: Role of procalcitonin,
C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis
factor-alpha in the diagnosis of neonatal sepsis. Turk J Pediatr.
49:7–20. 2007.PubMed/NCBI
|
|
14.
|
Shigematsu H, Lin L, Takahashi T, Nomura
M, Suzuki M, Wistuba II, Fong KM, Lee H, Toyooka S, Shimizu N, et
al: Clinical and biological features associated with epidermal
growth factor receptor gene mutations in lung cancers. J Natl
Cancer Inst. 97:339–346. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Lièvre A, Bachet J-B, Le Corre D, Boige V,
Landi B, Emile JF, Côté JF, Tomasic G, Penna C, Ducreux M, et al:
KRAS mutation status is predictive of response to cetuximab therapy
in colorectal cancer. Cancer Res. 66:3992–3995. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Sutherland AM and Walley KR:
Bench-to-bedside review: Association of genetic variation with
sepsis. Crit Care. 13:2102009. View
Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Menges T, König IR, Hossain H, Little S,
Tchatalbachev S, Thierer F, Hackstein H, Franjkovic I, Colaris T,
Martens F, et al: Sepsis syndrome and death in trauma patients are
associated with variation in the gene encoding tumor necrosis
factor. Crit Care Med. 36:1456–1462, e1–e6. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Chen G, Han N, Li G, Li X, Li G, Liu Y, Wu
W, Wang Y, Chen Y, Sun G, et al: Prediction of feature genes in
trauma patients with the TNF rs1800629 A allele using support
vector machine. Comput Biol Med. 64:24–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Fujita A, Sato JR, Rodrigues LO, Ferreira
CE and Sogayar MC: Evaluating different methods of microarray data
normalization. BMC Bioinformatics. 7:4692006. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Smyth GK: Limma: Linear models for
microarray data. Bioinformatics and computational biology solutions
using R and Bioconductor. Gentleman R, Carey VJ, Huber W, Irizarry
RA and Dudoit S: (New York). Springer. 397–420. 2005. View Article : Google Scholar
|
|
21.
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J R Stat Soc Series B Stat Methodol. 57:289–300.
1995.
|
|
22.
|
Duncan D, Prodduturi N and Zhang B:
WebGestalt2: An updated and expanded version of the Web-based Gene
Set Analysis Toolkit. BMC Bioinformatics. 11(Suppl 4): 102010.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9.1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res.
41:D808–D815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Smoot ME, Ono K, Ruscheinski J, Wang P-L
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Wei N and Deng XW: The COP9 signalosome.
Annu Rev Cell Dev Biol. 19:261–286. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Wu Y and Zhou BP:
TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and
invasion. Br J Cancer. 102:639–644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Schwartz JC, Podell ER, Han SS, Berry JD,
Eggan KC and Cech TR: FUS is sequestered in nuclear aggregates in
ALS patient fibroblasts. Mol Biol Cell. 25:2571–2578. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Bentmann E, Neumann M, Tahirovic S, Rodde
R, Dormann D and Haass C: Requirements for stress granule
recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein
of 43 kDa (TDP-43). J Biol Chem. 287:23079–23094. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Maruyama H, Morino H, Ito H, Izumi Y, Kato
H, Watanabe Y, Kinoshita Y, Kamada M, Nodera H, et al: Mutations of
optineurin in amyotrophic lateral sclerosis. Nature. 465:223–226.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Riggi N, Cironi L, Provero P, Suvà ML,
Stehle JC, Baumer K, Guillou L and Stamenkovic I: Expression of the
FUS-CHOP fusion protein in primary mesenchymal progenitor cells
gives rise to a model of myxoid liposarcoma. Cancer Res.
66:7016–7023. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Pintard L, Willis JH, Willems A, Johnson
JL, Srayko M, Kurz T, Glaser S, Mains PE, Tyers M, Bowerman B and
Peter M: The BTB protein MEL-26 is a substrate-specific adaptor of
the CUL-3 ubiquitin-ligase. Nature. 425:311–316. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Saito N, Sakakibara K, Sato T, Friedman
JM, Kufe DW, VonHoff DD and Kawabe T: CBS9106-induced CRM1
degradation is mediated by cullin ring ligase activity and the
neddylation pathway. Mol Cancer Ther. 13:3013–3023. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Tron AE, Arai T, Duda DM, Kuwabara H,
Olszewski JL, Fujiwara Y, Bahamon BN, Signoretti S, Schulman BA and
DeCaprio JA: The glomuvenous malformation protein Glomulin binds
Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7.
Mol Cell. 46:67–78. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
McEvoy JD, Kossatz U, Malek N and Singer
JD: Constitutive turnover of cyclin E by Cul3 maintains quiescence.
Mol Cell Biol. 27:3651–3666. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Singer JD, Gurian-West M, Clurman B and
Roberts JM: Cullin-3 targets cyclin E for ubiquitination and
controls S phase in mammalian cells. Genes Dev. 13:2375–2387. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Eide PW, Cekaite L, Danielsen SA,
Eilertsen IA, Kjenseth A, Fykerud TA, Ågesen TH, Bruun J, Rivedal
E, Lothe RA and Leithe E: NEDD4 is overexpressed in colorectal
cancer and promotes colonic cell growth independently of the
PI3K/PTEN/AKT pathway. Cell Signal. 25:12–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Yu S, Yi H, Wang Z and Dong J: Screening
key genes associated with congenital heart defects in Down syndrome
based on differential expression network. Int J Clin Exp Pathol.
8:8385–8393. 2015.PubMed/NCBI
|
|
39.
|
Zhang X, Howell GM, Guo L, Collage RD,
Loughran PA, Zuckerbraun BS and Rosengart MR: CaMKIV-dependent
preservation of mTOR expression is required for autophagy during
lipopolysaccharide-induced inflammation and acute kidney injury. J
Immunol. 193:2405–2415. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Qiao FS, Wei C, Yun J and Qian LX:
Insights into the molecular mechanisms in sepsis with microarray
technology. Eur Rev Med Pharmacol Sci. 18:2405–2412.
2014.PubMed/NCBI
|
|
41.
|
Geng J, Luo H, Pu Y, Zhou Z, Wu X, Xu W
and Yang Z: Methylation mediated silencing of miR-23b expression
and its role in glioma stem cells. Neurosci Lett. 528:185–189.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Ofir M, Hacohen D and Ginsberg D: MiR-15
and miR-16 are direct transcriptional targets of E2F1 that limit
E2F-induced proliferation by targeting cyclin E. Mol Cancer Res.
9:440–447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Wang X, Wang X, Liu X, Wang X, Xu J, Hou
S, Zhang X and Ding Y: miR-15a/16 are upregulated in the serum of
neonatal sepsis patients and inhibit the LPS-induced inflammatory
pathway. Int J Clin Exp Pathol. 8:5683–5690. 2015.
|
